• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
  • New
The Netter Collection of Medical Illustrations: Musculoskeletal System, Volume 6, Part III - Biology and Systemic Diseases

The Netter Collection of Medical Illustrations: Musculoskeletal System, Volume 6, Part III - Biology and Systemic Diseases

9780323880879
459.21 zł
390.33 zł Save 68.88 zł
Lowest price within 30 days before promotion: 390.33 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
Offering a concise, highly visual approach to the basic science and clinical pathology of the musculoskeletal system, this updated volume in The Netter Collection of Medical Illustrations (the CIBA Green Books) contains unparalleled didactic illustrations reflecting the latest medical knowledge. Revised by Drs. Joseph Iannotti, Richard Parker, Abby G. Abelson, Brendan M. Patterson, and other experts from the Cleveland Clinic, Biology and Systemic Diseases, Part 3 of Musculoskeletal System, Volume 6, integrates core concepts of anatomy, physiology, and other basic sciences with common clinical correlates across health, medical, and surgical disciplines. Classic Netter art, updated and new illustrations, and modern imaging continue to bring medical concepts to life and make this timeless work an essential resource for students, clinicians, and educators.
Product Details
Elsevier
100969
9780323880879
9780323880879

Data sheet

Publication date
2024
Issue number
3
Cover
hard cover
Pages count
368
Dimensions (mm)
241 x 292
Weight (g)
1400
  • The Netter Collection of Medical Illustrations: Musculoskeletal System, Volume 6, Part III - Biology and Systemic Diseases

    SECTION 1-EMBRYOLOGY

    DEVELOPMENT OF MUSCULOSKELETAL SYSTEM

    1-1 Amphioxus and Human Embryo at 16

    Days, 2

    1-2 Differentiation of Somites into Myotomes,

    Sclerotomes, and Dermatomes, 3

    1-3 Progressive Stages in Formation of

    Vertebral Column, Dermatomes, and

    Myotomes; Mesenchymal Precartilage

    Primordia of Axial and Appendicular

    Skeletons at 5 Weeks, 4

    1-4 Fate of Body, Costal Process, and Neural

    Arch Components of Vertebral Column,

    With Sites and Time of Appearance of

    Ossification Centers, 5

    1-5 First and Second Cervical Vertebrae at

    Birth; Development of Sternum, 6

    1-6 Early Development of Skull, 7

    1-7 Skeleton of Full-Term Newborn, 8

    1-8 Changes in Position of Limbs Before Birth;

    Precartilage Mesenchymal Cell

    Concentrations of Appendicular Skeleton

    at 6 Weeks, 9

    1-9 Changes in Ventral Dermatome Pattern

    During Limb Development, 10

    1-10 Initial Bone Formation in Mesenchyme;

    Early Stages of Flat Bone Formation, 11

    1-11 Secondary Osteon (Haversian

    System), 12

    1-12 Growth and Ossification of

    Long Bones, 13

    1-13 Growth in Width of a Bone and Osteon

    Remodeling, 14

    1-14 Remodeling: Maintenance of Basic

    Form and Proportions of Bone During

    Growth, 15

    1-15 Development of Three Types of Synovial

    Joints, 16

    1-16 Segmental Distribution of Myotomes in

    Fetus of 6 Weeks; Developing Skeletal

    Muscles at 8 Weeks, 17

    1-17 Development of Skeletal Muscle

    Fibers, 18

    1-18 Cross Sections of Body at 6 to

    7 Weeks, 19

    1-19 Prenatal Development of Perineal

    Musculature, 20

    1-20 Origins and Innervations of Pharyngeal

    Arch and Somite Myotome Muscles, 21

    1-21 Branchiomeric and Adjacent Myotomic

    Muscles at Birth, 22

    SECTION 2-PHYSIOLOGY

    2-1 Microscopic Appearance of Skeletal

    Muscle Fibers, 25

    2-2 Organization of Skeletal Muscle, 26

    2-3 Intrinsic Blood and Nerve Supply of

    Skeletal Muscle, 27

    2-4 Composition and Structure of

    Myofilaments, 28

    2-5 Muscle Contraction and Relaxation, 29

    2-6 Biochemical Mechanics of Muscle

    Contraction, 30

    2-7 Sarcoplasmic Reticulum and Initiation of

    Muscle Contraction, 31

    2-8 Initiation of Muscle Contraction by Electric

    Impulse and Calcium Movement, 32

    2-9 Motor Unit, 33

    2-10 Structure of Neuromuscular Junction, 34

    2-11 Physiology of Neuromuscular

    Junction, 35

    2-12 Pharmacology of Neuromuscular

    Transmission, 36

    2-13 Physiology of Muscle Contraction, 37

    2-14 Energy Metabolism of Muscle, 38

    2-15 Muscle Fiber Types, 39

    2-16 Structure, Physiology, and

    Pathophysiology of Growth Plate, 40-41

    2-17 Structure and Blood Supply of Growth

    Plate, 42

    2-18 Peripheral Fibrocartilaginous Element of

    Growth Plate, 43

    2-19 Composition and Structure of

    Cartilage, 44

    2-20 Bone Cells and Bone Deposition, 45

    2-21 Composition of Bone, 46

    2-22 Structure of Cortical (Compact) Bone, 47

    2-23 Structure of Trabecular Bone, 48

    2-24 Formation and Composition of

    Collagen, 49

    2-25 Formation and Composition of

    Proteoglycan, 50

    2-26 Structure and Function of Synovial

    Membrane, 51

    2-27 Histology of Connective Tissue, 52

    2-28 Dynamics of Bone Homeostasis, 53

    2-29 Regulation of Calcium and Phosphate

    Metabolism, 54

    2-30 Effects of Bone Formation and Bone

    Resorption on Skeletal Mass, 55

    2-31 Four Mechanisms of Bone Mass

    Regulation, 56

    2-32 Normal Calcium and Phosphate

    Metabolism, 57

    2-33 Nutritional Calcium Deficiency, 59

    2-34 Effects of Disuse and Stress (Weight

    Bearing) on Bone Mass, 60

    2-35 Musculoskeletal Effects of Weightlessness

    (Space Flight), 61

    2-36 Bone Architecture and Remodeling in

    Relation to Stress, 62

    2-37 Stress-Generated Electric Potentials in

    Bone, 63

    2-38 Bioelectric Potentials in Bone, 64

    2-39 Age-Related Changes in Bone

    Geometry, 65

    2-40 Age-Related Changes in Bone Geometry

    (Continued), 66

    SECTION 3-METABOLIC DISEASES

    3-1 Parathyroid Hormone, 68

    3-2 Pathophysiology of Primary

    Hyperparathyroidism, 69

    3-3 Clinical Manifestations of Primary

    Hyperparathyroidism, 70

    3-4 Differential Diagnosis of Hypercalcemic

    States, 71

    3-5 Pathologic Physiology of

    Hypoparathyroidism, 72

    3-6 Clinical Manifestations of Chronic

    Hypoparathyroidism, 74

    3-7 Clinical Manifestations of

    Hypocalcemia, 75

    3-8 Pseudohypoparathyroidism, 76

    3-9 Mechanism of Parathyroid Hormone

    Activity on End Organ, 77

    3-10 Mechanism of Parathyroid Hormone

    Activity on End Organ: Cyclic AMP

    Response to PTH, 78

    3-11 Clinical Guide to Parathyroid Hormone

    Assay: Different Forms of PTH and Their

    Detection by Whole (Bioactive) PTH and

    I-PTH Immunometric Assays, 79

    3-12 Clinical Guide to Parathyroid Hormone

    Assay (Continued), 80

    3-13 Childhood Rickets, 81

    3-14 Adult Osteomalacia, 82

    3-15 Nutritional Deficiency: Rickets and

    Osteomalacia, 83

    3-16 Vitamin D-Resistant Rickets and

    Osteomalacia due to Proximal Renal

    Tubular Defects (Hypophosphatemic

    Rachitic Syndromes), 84

    3-17 Vitamin D-Resistant Rickets and

    Osteomalacia due to Proximal and Distal

    Renal Tubular Defects, 85

    3-18 Vitamin D-Dependent (Pseudodeficiency)

    Rickets and Osteomalacia, 86

    3-19 Vitamin D-Resistant Rickets and

    Osteomalacia due to Renal Tubular

    Acidosis, 87

    3-20 Metabolic Aberrations of Renal

    Osteodystrophy, 88

    3-21 Rickets, Osteomalacia, and Renal

    Osteodystrophy, 89

    3-22 Bony Manifestations of Renal

    Osteodystrophy, 90

    3-23 Vascular and Soft Tissue Calcification in

    Secondary Hyperparathyroidism of

    Chronic Renal Disease, 91

    3-24 Clinical Guide to Vitamin D

    Measurement, 92

    3-25 Hypophosphatasia, 93

    3-26 Causes of Osteoporosis, 94

    3-27 Involutional Osteoporosis, 95

    3-28 Clinical Manifestations of

    Osteoporosis, 96

    3-29 Progressive Spinal Deformity in

    Osteoporosis, 97

    3-30 Radiology of Osteopenia, 98

    3-31 Radiology of Osteopenia (Continued), 99

    3-32 Radiology of Osteopenia (Continued), 100

    3-33 Transiliac Bone Biopsy, 101

    3-34 Treatment of Complications of Spinal

    Osteoporosis, 102

    3-35 Treatment of Osteoporosis, 103

    3-36 Treatment of Osteoporosis

    (Continued), 104

    3-37 Osteogenesis Imperfecta Type I, 106

    3-38 Osteogenesis Imperfecta Type III, 107

    3-39 Marfan Syndrome, 108

    3-40 Marfan Syndrome (Continued), 109

    3-41 Ehlers-Danlos Syndromes, 110

    3-42 Ehlers-Danlos Syndromes (Continued), 111

    3-43 Osteopetrosis (Albers-Schönberg

    Disease), 112

    3-44 Paget Disease of Bone, 113

    3-45 Paget Disease of Bone (Continued), 114

    3-46 Pathophysiology and Treatment of Paget

    Disease of Bone, 115

    3-47 Fibrodysplasia Ossificans Progressiva, 116

    SECTION 4-CONGENITAL AND

    DEVELOPMENTAL DISORDERS

    DWARFISM

    4-1 Achondroplasia-Clinical

    Manifestations, 118

    4-2 Achondroplasia-Clinical Manifestations

    (Continued), 119

    4-3 Achondroplasia-Clinical Manifestations of

    Spine, 120

    4-4 Achondroplasia-Diagnostic Testing, 121

    4-5 Hypochondroplasia, 122

    4-6 Diastrophic Dwarfism, 123

    4-7 Pseudoachondroplasia, 124

    4-8 Metaphyseal Chondrodysplasia, McKusick

    Type, 125

    4-9 Metaphyseal Chondrodysplasia, Schmid

    Type, 126

    4-10 Chondrodysplasia Punctata, 127

    4-11 Chondroectodermal Dysplasia (Ellis-van

    Creveld Syndrome), Grebe

    Chondrodysplasia, and Acromesomelic

    Dysplasia, 128

    4-12 Multiple Epiphyseal Dysplasia, Fairbank

    Type, 129

    4-13 Pycnodysostosis (Pyknodysostosis), 130

    4-14 Camptomelic (Campomelic)

    Dysplasia, 131

    4-15 Spondyloepiphyseal Dysplasia Tarda

    and Spondyloepiphyseal Dysplasia

    Congenita, 132

    4-16 Spondylocostal Dysostosis and Dyggve-

    Melchior-Clausen Dysplasia, 133

    4-17 Kniest Dysplasia, 134

    4-18 Mucopolysaccharidoses, 135

    4-19 Principles of Treatment of Skeletal

    Dysplasias, 136

    NEUROFIBROMATOSIS

    4-20 Diagnostic Criteria and Cutaneous Lesions

    in Neurofibromatosis, 137

    4-21 Cutaneous Lesions in

    Neurofibromatosis, 138

    4-22 Spinal Deformities in

    Neurofibromatosis, 139

    4-23 Bone Overgrowth and Erosion in

    Neurofibromatosis, 140

    OTHER

    4-24 Arthrogryposis Multiplex Congenita, 141

    4-25 Fibrodysplasia Ossificans Progressiva and

    Progressive Diaphyseal Dysplasia, 142

    4-26 Osteopetrosis and Osteopoikilosis, 143

    4-27 Melorheostosis, 144

    4-28 Congenital Elevation of Scapula, Absence

    of Clavicle, and Pseudarthrosis of

    Clavicle, 145

    4-29 Madelung Deformity, 146

    4-30 Congenital Bowing of the Tibia, 147

    4-31 Congenital Pseudoarthrosis of the Tibia

    and Dislocation of the Knee, 148

    LEG-LENGTH DISCREPANCY

    4-32 Clinical Manifestations, 149

    4-33 Evaluation of Leg-Length Discrepancy, 150

    4-34 Charts for Timing Growth Arrest and

    Determining Amount of Limb Lengthening

    to Achieve Limb-Length Equality at

    Maturity, 151

    4-35 Growth Arrest, 152

    4-36 Ilizarov and De Bastiani Techniques for

    Limb Lengthening, 153

    CONGENITAL LIMB MALFORMATION

    4-37 Growth Factors, 154

    4-38 Foot Prehensility in Amelia, 155

    4-39 Failure of Formation of Parts: Transverse

    Arrest, 156

    4-40 Failure of Formation of Parts: Transverse

    Arrest (Continued), 157

    4-41 Failure of Formation of Parts: Transverse

    Arrest (Continued), 158

    4-42 Failure of Formation of Parts: Transverse

    Arrest (Continued), 159

    4-43 Failure of Formation of Parts: Transverse

    Arrest (Continued), 160

    4-44 Failure of Formation of Parts: Transverse

    Arrest (Continued), 161

    4-45 Failure of Formation of Parts: Transverse

    Arrest (Continued), 162

    4-46 Failure of Formation of Parts: Longitudinal

    Arrest, 163

    4-47 Failure of Formation of Parts: Longitudinal

    Arrest (Continued), 164

    4-48 Failure of Formation of Parts: Longitudinal

    Arrest (Continued), 165

    4-49 Failure of Formation of Parts: Longitudinal

    Arrest (Continued), 166

    4-50 Duplication of Parts, Overgrowth, and

    Congenital Constriction Band

    Syndrome, 167

    SECTION 5-RHEUMATIC DISEASES

    RHEUMATIC DISEASES

    5-1 Joint Pathology in Rheumatoid

    Arthritis, 170

    5-2 Early and Moderate Hand Involvement in

    Rheumatoid Arthritis, 171

    5-3 Advanced Hand Involvement in

    Rheumatoid Arthritis, 172

    5-4 Foot Involvement in Rheumatoid

    Arthritis, 173

    5-5 Knee, Shoulder, and Hip Joint Involvement

    in Rheumatoid Arthritis, 174

    5-6 Extra-articular Manifestations in

    Rheumatoid Arthritis, 175

    5-7 Extra-articular Manifestations in

    Rheumatoid Arthritis (Continued), 176

    5-8 Immunologic Features in Rheumatoid

    Arthritis, 177

    5-9 Variable Clinical Course of Adult

    Rheumatoid Arthritis, 178

    TREATMENT OF RHEUMATOID ARTHRITIS

    5-10 Exercises for Upper Extremities, 179

    5-11 Exercises for Shoulders and Lower

    Extremities, 180

    5-12 Surgical Management in Rheumatoid

    Arthritis, 181

    SYNOVIAL FLUID EXAMINATION

    5-13 Techniques for Aspiration of

    Joint Fluid, 182

    5-14 Synovial Fluid Examination, 183

    5-15 Synovial Fluid Examination

    (Continued), 184

    JUVENILE ARTHRITIS

    5-16 Systemic Juvenile Arthritis, 185

    5-17 Systemic Juvenile Arthritis

    (Continued), 186

    5-18 Hand Involvement in Juvenile

    Arthritis, 187

    5-19 Lower Limb Involvement in Juvenile

    Arthritis, 188

    5-20 Ocular Manifestations in Juvenile

    Arthritis, 189

    5-21 Sequelae of Juvenile Arthritis, 190

    OSTEOARTHRITIS

    5-22 Distribution of Joint Involvement in

    Osteoarthritis, 191

    5-23 Clinical Findings in Osteoarthritis, 192

    5-24 Clinical Findings in Osteoarthritis

    (Continued), 193

    5-25 Hand Involvement in Osteoarthritis, 194

    5-26 Hip Joint Involvement in

    Osteoarthritis, 195

    5-27 Degenerative Changes, 196

    5-28 Spine Involvement in Osteoarthritis, 197

    OTHER

    5-29 Ankylosing Spondylitis, 198

    5-30 Ankylosing Spondylitis (Continued), 199

    5-31 Ankylosing Spondylitis (Continued)

    Degenerative Changes in the Cervical

    Vertebrae, 200

    5-32 Psoriatic Arthritis, 201

    5-33 Reactive Arthritis (formerly Reiter

    Syndrome), 202

    5-34 Infectious Arthritis, 203

    5-35 Tuberculous Arthritis, 204

    5-36 Hemophilic Arthritis, 205

    5-37 Neuropathic Joint Disease, 206

    5-38 Gouty Arthritis, 207

    5-39 Tophaceous Gout, 208

    5-40 Articular Chondrocalcinosis

    (Pseudogout), 209

    5-41 Nonarticular Rheumatism, 210

    5-42 Clinical Manifestations of Polymyalgia

    Rheumatica and Giant Cell Arteritis, 211

    5-43 Imaging of Polymyalgia Rheumatica and

    Giant Cell Arteritis, 212

    5-44 Fibromyalgia, 213

    5-45 Pathophysiology of Autoinflammatory

    Syndromes, 214

    5-46 Cutaneous Findings in Autoinflammatory

    Syndromes, 215

    5-47 Joint and Central Nervous System Findings

    in Autoinflammatory Syndromes, 216

    5-48 Vasculitis: Vessel Distribution, 217

    5-49 Vasculitis: Clinical and Histologic Features

    of Granulomatosis with Polyangitis

    (Wegener), 218

    5-50 Key Features of Primary Vasculitic

    Diseases, 219

    5-51 Renal Lesions in Systemic Lupus

    Erythematosus, 220

    5-52 Cutaneous Lupus Band Test, 221

    5-53 Lupus Erythematosus of the Heart, 222

    5-54 Antiphospholipid Syndrome, 223

    5-55 Scleroderma-Clinical Manifestations, 225

    5-56 Scleroderma-Clinical Findings, 226

    5-57 Scleroderma-Radiographic Findings of

    Acro-osteolysis and Calcinosis Cutis, 227

    5-58 Polymyositis and Dermatomyositis, 228

    5-59 Polymyositis and Dermatomyositis

    (Continued), 229

    5-60 Primary Angiitis of the Central Nervous

    System, 230

    5-61 Behçet Syndrome, 232

    5-62 Behçet Syndrome (Continued), 233

    SECTION 6-TUMORS OF

    MUSCULOSKELETAL SYSTEM

    6-1 Initial Evaluation and Staging of

    Musculoskeletal Tumors, 236

    6-2 Osteoid Osteoma, 238

    6-3 Osteoblastoma, 239

    6-4 Enchondroma, 240

    6-5 Periosteal Chondroma, 241

    6-6 Osteocartilaginous Exostosis

    (Osteochondroma), 242

    6-7 Chondroblastoma and Chondromyxoid

    Fibroma, 243

    6-8 Fibrous Dysplasia, 244

    6-9 Nonossifying Fibroma and Desmoplastic

    Fibroma, 245

    6-10 Eosinophilic Granuloma, 246

    6-11 Aneurysmal Bone Cyst, 247

    6-12 Simple Bone Cyst, 248

    6-13 Giant Cell Tumor of Bone, 249

    6-14 Osteosarcoma, 250

    6-15 Osteosarcoma (Continued), 251

    6-16 Osteosarcoma (Continued), 252

    6-17 Chondrosarcoma, 253

    6-18 Fibrous Histiocytoma and Fibrosarcoma of

    Bone, 254

    6-19 Reticuloendothelial Tumors-Ewing

    Sarcoma, 255

    6-20 Reticuloendothelial Tumors-

    Myeloma, 256

    6-21 Adamantinoma, 257

    6-22 Tumors Metastatic to Bone, 258

    6-23 Desmoid, Fibromatosis, and

    Hemangioma, 259

    6-24 Lipoma, Neurofibroma, and Myositis

    Ossificans, 260

    6-25 Sarcomas of Soft Tissue, 261

    6-26 Sarcomas of Soft Tissue (Continued), 262

    6-27 Sarcomas of Soft Tissue (Continued), 263

    6-28 Tumor Biopsy, 264

    6-29 Surgical Margins, 265

    6-30 Reconstruction after Partial Excision

    or Curettage of Bone (Fracture

    Prophylaxis), 266

    6-31 Limb-Salvage Procedures for

    Reconstruction, 267

    6-32 Radiologic Findings in Limb-Salvage

    Procedures, 268

    6-33 Limb-Salvage Procedures, 269

    SECTION 7-INJURY TO

    MUSCULOSKELETAL SYSTEM

    7-1 Closed Soft Tissue Injuries, 272

    7-2 Open Soft Tissue Wounds, 273

    7-3 Treatment of Open Soft Tissue

    Wounds, 274

    7-4 Pressure Ulcers, 275

    7-5 Excision of Deep Pressure Ulcer, 276

    7-6 Classification of Burns, 277

    7-7 Causes and Clinical Types of Burns, 278

    7-8 Escharotomy for Burns, 279

    7-9 Prevention of Infection in Burn

    Wounds, 280

    7-10 Metabolic and Systemic Effects of

    Burns, 281

    7-11 Excision and Grafting for Burns, 282

    7-12 Etiology of Compartment Syndrome, 283

    7-13 Pathophysiology of Compartment and

    Crush Syndromes, 284

    7-14 Acute Anterior Compartment

    Syndrome, 285

    7-15 Measurement of Intracompartmental

    Pressure, 286

    7-16 Incisions for Compartment Syndrome of

    Forearm and Hand, 287

    7-17 Incisions for Compartment Syndrome of

    Leg, 288

    7-18 Healing of Incised, Sutured Skin

    Wound, 289

    7-19 Healing of Excised Skin

    Wound, 290

    7-20 Types of Joint Injury, 291

    7-21 Classification of Fracture, 292

    7-22 Types of Displacement, 293

    7-23 Types of Fracture, 294

    7-24 Healing of Fracture, 295

    7-25 Primary Union, 296

    7-26 Factors That Promote or Delay Bone

    Healing, 297

    SECTION 8-SOFT TISSUE INFECTIONS

    8-1 Septic Joint, 300

    8-2 Etiology and Prevalence of Hematogenous

    Osteomyelitis, 301

    8-3 Pathogenesis of Hematogenous

    Osteomyelitis, 302

    8-4 Clinical Manifestations of Hematogenous

    Osteomyelitis, 303

    8-5 Direct (Nonhematogenous) Causes of

    Osteomyelitis, 304

    8-6 Direct (Nonhematogenous) Causes of

    Osteomyelitis (Continued), 305

    8-7 Osteomyelitis after Open Fracture, 306

    8-8 Recurrent Postoperative

    Osteomyelitis, 307

    8-9 Delayed Posttraumatic Osteomyelitis in

    Diabetic Patient, 308

    SECTION 9-COMPLICATIONS

    OF FRACTURE

    9-1 Neurovascular Injury, 310

    9-2 Adult Respiratory Distress

    Syndrome, 311

    9-3 Infection, 312

    9-4 Surgical Management of Open

    Fractures, 313

    9-5 Gas Gangrene, 314

    9-6 Implant Failure, 315

    9-7 Malunion of Fracture, 316

    9-8 Growth Deformity, 317

    9-9 Posttraumatic Osteoarthritis, 318

    9-10 Osteonecrosis, 319

    9-11 Joint Stiffness, 320

    9-12 Complex Regional Pain Syndrome, 321

    9-13 Nonunion of Fracture, 322

    9-14 Surgical Management of Nonunion, 323

    9-15 Electric Stimulation of Bone Growth, 324

    9-16 Noninvasive Coupling Methods of Electric

    Stimulation of Bone, 325

Comments (0)